Skip to main content
. 2024 Jan 15;209(2):137–152. doi: 10.1164/rccm.202306-1113ST

Table 1.

PICO Questions for Systemic Sclerosis–associated Interstitial Lung Disease Therapies Assessed

Question Therapy
1 Should patients with SSc-ILD be treated with cyclophosphamide?
2 Should patients with SSc-ILD be treated with mycophenolate?
3 Should patients with SSc-ILD be treated with rituximab?
4 Should patients with SSc-ILD be treated with tocilizumab?
5 Should patients with SSc-ILD be treated with nintedanib?
6 Should patients with SSc-ILD be treated with nintedanib plus mycophenolate?
7 Should patients with SSc-ILD be treated with pirfenidone?
8 Should patients with SSc-ILD be treated with pirfenidone plus mycophenolate?

Definition of abbreviation: PICO = population, intervention, comparison, outcome; SSc-ILD =  systemic sclerosis–associated interstitial lung disease.